The U.S. healthcare sector looks set for a bulked up profile in
growth indexes when FTSE Russell reconstitutes its stock indexes late
next Friday, an annual event that historically creates one of the
biggest trading volume days of the year.
The Russell rebalance becomes final on the fourth Friday every June,
after markets close. Stocks are added or deleted from Russell’s family
of indexes, including the Russell 1000 large cap and Russell 2000 small
cap, prompting fund managers to adjust portfolios to reflect new
weightings and components.
Russell bases the placesment in the indexes on a number of factors,
including market capitalization, voting rights requirements and country
of domicile.
Telegraphing the reconstitution can create additional buying and
selling stocks. Some investors may use the additional liquidity to take
advantage of any resulting price dislocations, or to adjust the holdings
in their portfolios, especially in smaller companies that have much
lower liquidity.
The resulting surge in trading volume crests right before the market
close. FTSE Russell says more than $15 trillion is currently benchmarked
to its indexes globally and about $9 trillion to its U.S. indexes.
“I’m already at the spot where I will be happy when Russell is behind
us because it is an emotionally elevated day, everybody has to really
be on their toes, there is a lot of messages and a lot of traffic coming
down,” said Gordon Charlop, a managing director at Rosenblatt
Securities in New York.
The New York Stock Exchange and Nasdaq, because of the scale of the
revamp, reinforces the rules for trades on the close and contingency
plans in the event of unusual market conditions. During the June 2019
reconstitution, Nasdaq said 1.279 billion shares representing $42.59
billion were executed in its “closing cross” in 1.14 seconds across
Nasdaq listed stocks.
This year’s reconstitution is also influenced by market volatility
generated by the COVID-19 pandemic. While other index providers delayed
rebalancing that was scheduled for earlier in the year, FTSE Russell has
moved forward with the reconstitution as originally scheduled.
“Our policy team did consult the market on whether any temporary
measures were needed to accommodate the market volatility and the
overwhelming feedback was that it wasn’t required and we should proceed
according to the published rules,” said Catherine Yoshimoto, director,
product management at FTSE Russell.
The influence of the novel coronavirus will also create more movement
between the indexes than in recent years. Virtu Financial estimates
turnover across the Russell 3000 to be $57 billion compared with the $35
billion last year.
In addition, the coronavirus has aided the strong performance of
healthcare stocks and other names that have benefited from the “stay at
home” environment, some of which are likely to be added directly, or
promoted to, the large cap Russell 1000.
Lori Calvasina, head of U.S. Equity Strategy at RBC Capital Markets
anticipates nearly half of the stocks being promoted to the Russell 1000
from the Russell 2000 will be healthcare names.
Teladoc, which offers virtual healthcare services, has risen more
than 130% this year and is widely expected to be promoted to the Russell
large cap index. Home fitness provider Peloton is seen as being added
directly to the Russell 1000. Of the six initial public offerings being
added to the Russell 2000, all belong to the healthcare space.
Jefferies anticipates the healthcare weight in the Russell 2000 to
decrease by 1.7% as a result of these promotions, while forecasting the
healthcare weight in the Russell 2000 growth index at 33%, with 17% due
to biotech names.
The firm sees the weighting for healthcare increasing by 5.9% in the
Russell Midcap growth index and 1% in the Russell 1000 growth index.
“Obviously healthcare is the cure to this pandemic, so anything and
everything in healthcare has generally worked pretty well,” said Steve
DeSanctis, equity strategist at Jefferies in New York.
“There are so many companies that are trying stuff. Who knows who is going to win or lose out of this?”
https://www.reuters.com/article/us-usa-stocks-weekahead/wall-street-week-ahead-healthcare-to-get-growth-bump-in-covid-19-influenced-russell-remake-idUSKBN23Q2UK